Adverse Reactions to Iodinated Contrast Media

Wendy Bottinor; Pritam Polkampally; Ion Jovin

doi:10.1055/s-0033-1348885

International Journal of Angiology, Table of Contents

Int J Angiol 2013; 22(03): 149-154
DOI: 10.1055/s-0033-1348885

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Adverse Reactions to Iodinated Contrast Media

Wendy Bottinor

¹Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia

,

Pritam Polkampally

²Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia

,

Ion Jovin

²Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, Virginia

³Department of Medicine/Cardiac Catheterization Laboratory, McGuire Veterans Affairs Medical Center, Richmond, Virginia

› Author Affiliations

Abstract

The use of iodinated contrast agents for angiography dates back to the 1920s. With over 75 million contrast-requiring procedures performed annually worldwide, it is important to understand the risk factors, pathogenesis, diagnosis, prevention, and treatment of adverse reactions caused by iodinated contrast media (ICM). As contrast media have evolved from ionic, high-osmolality to nonionic, low-osmolality formulations the risk of reactions has decreased over time; however, no pretreatment protocol has been shown to eliminate all repeat reactions. Clinical alertness and early recognition of adverse reactions is of paramount importance and key for appropriate management of these patients. In this article, we review the most recent literature regarding adverse reactions to ICM and provide an insight into the pathogenesis, clinical presentation, pretreatment, and management of contrast-related reactions.

Keywords

iodinated contrast media - contrast allergy - contrast prophylaxis - contrast nephropathy

Full Text

References

References
1 Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001; 11 (7) 1267-1275
2 Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol 2008; 36 (2) 69-74 , quiz 76–77
3 Thomsen HS, Morcos SK. Radiographic contrast media. BJU Int 2000; 86 (Suppl. 01) 1-10
4 Christiansen C. X-ray contrast media—an overview. Toxicology 2005; 209 (2) 185-187
5 Shehadi WH. Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med 1975; 124 (1) 145-152
6 Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175 (3) 621-628
7 Bush WH, Swanson DP. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol 1991; 157 (6) 1153-1161
8 Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997; 203 (3) 605-610
9 Almén T. The etiology of contrast medium reactions. Invest Radiol 1994; 29 (Suppl. 01) S37-S45
10 Laroche D, Namour F, Lefrançois C , et al. Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy 1999; 54 (Suppl. 58) 13-16
11 Dewachter P, Laroche D, Mouton-Faivre C , et al. Immediate reactions following iodinated contrast media injection: a study of 38 cases. Eur J Radiol 2011; 77 (3) 495-501
12 Christiansen C. Late-onset allergy-like reactions to X-ray contrast media. Curr Opin Allergy Clin Immunol 2002; 2 (4) 333-339
13 Brockow K, Christiansen C, Kanny G , et al; ENDA; EAACI interest group on drug hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60 (2) 150-158
14 Lerch M, Keller M, Britschgi M , et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 2007; 119 (6) 1529-1536
15 Keller M, Lerch M, Britschgi M , et al. Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells. Clin Exp Allergy 2010; 40 (2) 257-268
16 Kounis NG, Davlouros P, Hahalis G, Mazarakis A. The heart seems to be the primary site and the target of anaphylaxis resulting in the development of Kounis syndrome. Intern Emerg Med 2012; 7 (Suppl. 02) S119-S120
17 Matucci A, Vultaggio A, Fassio F, Rossi O, Maggi E. Heart as the early main target of severe anaphylactic reactions: two case reports. Intern Emerg Med 2011; 6 (5) 467-469
18 Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154 (6) 2855-2865
19 Yoshikawa H. Late adverse reactions to nonionic contrast media. Radiology 1992; 183 (3) 737-740
20 Burton PR, Jarmolowski E, Raineri F, Buist MD, Wriedt CH. A severe, late reaction to radiological contrast media mimicking a sepsis syndrome. Australas Radiol 1999; 43 (3) 360-362
21 Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc 2005; 26 (3) 199-203
22 Hagan JB. Anaphylactoid and adverse reactions to radiocontrast agents. Immunol Allergy Clin North Am 2004; 24 (3) 507-519 , vii–viii
23 Wolf GL, Mishkin MM, Roux SG , et al. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991; 26 (5) 404-410
24 Thomsen HS, Bush Jr WH. Adverse effects of contrast media: incidence, prevention and management. Drug Saf 1998; 19 (4) 313-324
25 Levine GN, Bates ER, Blankenship JC , et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124 (23) e574-e651
26 Rihal CS, Textor SC, Grill DE , et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105 (19) 2259-2264
27 From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 2008; 83 (10) 1095-1100
28 Stacul F, van der Molen AJ, Reimer P , et al; Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21 (12) 2527-2541
29 Esplugas E, Cequier A, Jara F , et al. Risk of thrombosis during coronary angioplasty with low osmolality contrast media. Am J Cardiol 1991; 68 (10) 1020-1024
30 Schräder R. Thrombogenic potential of non-ionic contrast media—fact or fiction?. Eur J Radiol 1996; 23 (Suppl. 01) S10-S13
31 Georgakis A, Ener RA, Jin J , et al. Risk of thrombogenicity among nonionic radiocontrast agents. J Invasive Cardiol 2008; 20 (7) 349-353
32 Trivedi H, Nadella R, Szabo A. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Clin Nephrol 2010; 74 (4) 288-296
33 Morcos SK, Thomsen HS, Webb JA. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 2001; 11 (9) 1720-1728
34 Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991; 87 (4) 867-872
35 Lasser EC, Berry CC, Mishkin MM, Williamson B, Zheutlin N, Silverman JM. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. AJR Am J Roentgenol 1994; 162 (3) 523-526
36 Williams AN, Kelso JM. Radiocontrast-induced anaphylaxis despite pretreatment and use of iso-osmolar contrast. Ann Allergy Asthma Immunol 2007; 99 (5) 467-468